Morphological and Functional Characteristic of Senescent Cancer Cells
Journal:
Current Drug Targets
Volume:
17
Page:
377-387
Author(s):
Ewa Sikora, Grazyna Mosieniak and Malgorzata Alicja Sliwinska
Implication of Unfolded Protein Response and Autophagy in the Treatment of BRAF Inhibitor Resistant Melanoma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
291-298
Author(s):
Xiao-Xiao Meng, Hong-Xi Xu, Mu Yao, Qihan Dong and Xu Dong Zhang
Hijacking the Hedgehog Pathway in Cancer Therapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
309-317
Author(s):
Mikko O. Laukkanen and Maria Domenica Castellone
The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
275-286
Author(s):
Jui-Ling Tsai, Yu-May Lee, Chien-Yuan Pan and Alan Yueh-Luen Lee
Ideal and Reality: Barricade in the Delivery of Small Interfering RNA for Cancer Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
17
Page:
237-247
Author(s):
Di Wu, Haobo Han, Zhen Xing, Jianxu Zhang, Li Li, Wei Shi and Quanshun Li
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
261-274
Author(s):
Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo Serra
Natural Endoperoxides as Drug Lead Compounds
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
383-405
Author(s):
Ming Bu, Burton B. Yang and Liming Hu
New Generation of Oncolytic Herpes Virus
Journal:
Current Cancer Therapy Reviews
Volume:
11
Page:
163-177
Author(s):
Hiroshi Fukuhara and Tomoki Todo
Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
16
Page:
391-403
Author(s):
Mo Chen, Alec Peters, Tao Huang and Xiaolin Nan
MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
933-939
Author(s):
Morteza Ghandadi and Amirhossein Sahebkar